Mechanistic comparison of Deanol and Sorbic Acid Mold and yeast inhibitor. Used as based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
2
Shared Targets
29%
Jaccard Similarity
24%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Deanol and Sorbic share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.286 means 29% of the combined target set is bound by both compounds. The IDF-weighted score of 0.237 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Deanol and Sorbic have in common?
Deanol and Sorbic share 2 molecular targets with a Jaccard similarity of 29%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Deanol and Sorbic be combined?
Deanol and Sorbic share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Deanol or Sorbic?
In the BiohacksAI corpus: Deanol has 150 PubMed-indexed studies, Sorbic has 300 studies.